Moderate temperature reduction is sufficient for prevention of 5-fluorouracil-induced oral mucositis: an experimental in vivo study in rats.

PURPOSE: The current idea of how oral mucositis (OM) develops is primarily based on hypotheses and the early events which precede clinically established OM remain to be demonstrated. Cryotherapy (CT) continues to have considerable promise in clinical settings to reduce chemotherapy-induced OM. Although being effective, the knowledge is scarce regarding the ideal temperature for prevention of OM. Thus, the present study had two main objectives: (i) to develop an animal model to investigate the early events of OM; (ii) to study at what cooling temperature these early events could be abolished. METHODS: Male Sprague-Dawley rats were anaesthetized and given an intravenous bolus dose with the cytostatic drug fluorouracil (5-FU). During the first hour following injection with 5-FU, the oral cavity of the rats was cooled to a mucosal temperature at the range of 15-30 â—‹C, or left uncooled (35 â—‹C), serving as control. After 3-5 days, the rats were euthanized, and the buccal mucosa was excised. Subsequently, mucosal thickness and expression of IL-6 and TNF-α were analyzed with immunohistochemistry and enzyme-linked immunosorbent assay (ELISA). RESULTS: Five days following treatment with 5-FU, a statistically significant thickening of the oral mucosa occurred, and a distinct expression of both IL-6 and TNF-α were observed. The cryo-treated groups (15-30 °C) displayed statistically significantly thinner mucosa as compared to the control group (35 °C). The ELISA showed an increase in expression of the proinflammatory cytokines IL-6 and TNF-α in tissues exposed to 5-FU that were treated with increasing temperatures (15-30 °C). CONCLUSION: Bolus i.v. injection with 5-FU in rats can be used to create a functional animal model for chemotherapy-induced OM. Further, moderate temperature reduction is sufficient to reduce the early events which may precede clinically established OM.

Collagen matrix as an inlay in endoscopic skull base reconstruction.

BACKGROUND: Multi-layer reconstruction has become standard in endoscopic skull base surgery. The inlay component used can vary among autografts, allografts, xenografts and synthetics, primarily based on surgeon preference. The short- and long-term outcomes of collagen matrix in skull base reconstruction are described. METHODS: A case series of patients who underwent endoscopic skull base reconstruction with collagen matrix inlay were assessed. Immediate peri-operative outcomes (cerebrospinal fluid leak, meningitis, ventriculitis, intracranial bleeding, epistaxis, seizures) and delayed complications (delayed healing, meningoencephalocele, prolapse of reconstruction, delayed cerebrospinal fluid leak, ascending meningitis) were examined. RESULTS: Of 120 patients (51.0 ± 17.5 years, 41.7 per cent female), peri-operative complications totalled 12.7 per cent (cerebrospinal fluid leak, 3.3 per cent; meningitis, 3.3 per cent; other intracranial infections, 2.5 per cent; intracranial bleeding, 1.7 per cent; epistaxis, 1.7 per cent; and seizures, 0 per cent). Delayed complications did not occur in any patients. CONCLUSION: Collagen matrix is an effective inlay material. It provides robust long-term separation between sinus and cranial cavities, and avoids donor site morbidity, but carries additional cost.

Tantalum trabecular metal implants in anterior cervical corpectomy and fusion: 2-year prospective analysis.

Anterior cervical decompression for two or more cervical spondylotic levels can be performed using either multiple anterior cervical discectomies and fusion or anterior cervical corpectomy and fusion (ACCF). A variety of options for ACCF implants exist but to our knowledge, there is no clinical data for the use of tantalum trabecular metal implants (TTMI) for ACCF. A retrospective review was performed of prospectively collected data for ten patients undergoing ACCF with TTMI between 2011 and 2012. Radiological outcome was assessed by measuring the change in cervical (C) lordosis (fusion Cobb and C2-C7 Cobb), graft subsidence (anterior/posterior, determined by the subsidence of anterior/posterior body height of fused segments; cranial/caudal, determined by the cranial/caudal plate-to-disc distances) and rate of fusion using lateral cervical X-rays of patients at 0, 6, 12 and 24months post-operatively. The Neck Disability Index (NDI) assessed clinical outcome pre-operatively and at 6, 12 and 24months post-operatively. Cervical lordosis (Cobb angle of fused segment) was 5.2° (± 4.2°) at 0months and 6.0° (± 5.7°) at 24months post-operatively. Graft subsidence was observed to occur at 6months post-operatively and continued throughout follow-up. Anterior, posterior and caudal subsidence occurred more in the first 12months post-operatively than in the following 12months (p<0.05). Average pre-operative NDI was 45%. Average NDIs were 18%, 13% and 10% at 6, 12 and 24months post-operatively, respectively. ACCF patients treated with TTMI demonstrated stable cervical lordosis over 2years of follow-up and 100% fusion rates after 2years. Measures of subsidence appeared to decrease with time. Patients experienced improved clinical outcomes over the 2-year period.

Proliferation of the human urothelium is induced by atypical ß1 -adrenoceptors.

We wanted to assess whether ß-adrenoceptors mediate proliferation in the normal and malignant urothelial cell lines UROtsa and T24, respectively. Urothelial cells were cultured for 24 h in the presence of the ß-adrenoceptor agonists isoprenaline (ß1/2/3 ), dobutamine (ß1 ), salbutamol (ß2 ), BRL 37344 (ß3 ), CGP 12177 (a partial ß-agonist) or ß-adrenoceptor antagonists (metoprolol; ß1 , propranolol; ß1/2 ). Phosphorylation of kinases was screened with a Human Phospho-Kinase Array Kit (R&D systems). Intracellular pathways activated by proliferation of urothelial cells were characterized by incubating cells with the MEK1/2 inhibitor PD 98,059, the p38 kinase inhibitor losmapimod or with the Akt 1/2 kinase inhibitor. Proliferation was assessed with the MTT proliferation assay (ATCC). Western blot and immunocytochemistry were used for detection of the ß1 -adrenoceptor. Isoprenaline and dobutamine induced proliferation, while salbutamol and BRL 37344 did not. Dobutamine-induced proliferation was not affected by metoprolol or propranolol but was instead antagonized by CGP 12177 in T24 but not in UROtsa. In response to stimulation with dobutamine, Akt1/2/3 was phosphorylated in UROtsa, while ERK1/2 and p38 were phosphorylated in T24. MEK1/2 inhibition blocked basal and dobutamine-induced proliferation in T24 but only basal proliferation in UROtsa. Losmapimod slightly inhibited basal proliferation in T24 but not dobutamine-induced proliferation. Akt 1/2 inhibitor blocked basal and dobutamine-induced proliferation in UROtsa. Immunocytochemistry and Western blot revealed expression of ß1 -adrenoceptors in both urothelial cell lines. The present data show that the urothelium expresses atypical ß1-adrenoceptors that activate intracellular kinases inducing urothelial proliferation.

Zooming in on size distribution patterns underlying species coexistence in Baltic Sea phytoplankton.

Scale is a key to determining which processes drive community structure. We analyse size distributions of phytoplankton to determine time scales at which we can observe either fixed environmental characteristics underlying communities structure or competition-driven size distributions. Using multiple statistical tests, we characterise size distributions of phytoplankton from 20-year time series in two sites of the Baltic Sea. At large temporal scales (5-20 years), size distributions are unimodal, indicating that fundamental barriers to existence are here subtler than in other systems. Frequency distributions of the average size of the species weighted by biovolume are multimodal over large time scales, although this is the product of often unimodal short-term (<1 year) patterns. Our study represents a much-needed structured, high-resolution analysis of phytoplankton size distributions, revealing that short-term analyses are necessary to determine if, and how, competition shapes them. Our results provide a stepping-stone on which to further investigate the intricacies of competition and coexistence.

Ovarian follicular dynamics after cauterization of the dominant follicle in anestrous ewes.

An experiment was conducted to ascertain if follicles could reach ovulatory size after the largest follicle (dominant) has been removed at different times during a progestin treatment in anestrous ewes, and secondly to determine if these new follicles could respond to an hCG-induced ovulation and have similar function as corpora lutea. Mature crossbred sheep (n=44) in anestrous were treated with an intravaginal sponge containing 40 mg of FGA (day 0=sponge insertion) for 9 days. Treatments consisted of cauterization of the largest follicle on the experimental day 3 (T1), day 6 (T2) and day 9 (T3); day 12 to ascertain the size of the largest follicle in control ewes. During laparotomies, the diameters of the largest follicle (DF), and those of the second and third largest follicles (SF1 and SF2, respectively) were determined. On day 12, a second laparotomy was performed for those ewes which had their DF cauterized on days 3, 6 and 9, a fourth group was left intact and only laparotomized on day 12. At this time, the size of the new DF, SF1 and SF2 were determined. Immediately after the laparotomy on day 12, all the ewes were treated with 1000 i.u. of hCG to induce ovulation. Blood samples were collected daily from day 0 to 50 and samples were analyzed for progesterone concentrations. The size of the DF at the time of sponge removal was smaller that those observed on day 3 or 6 of sponge suggesting that follicles in ewes treated with this progestin regress and a new wave of follicular development ensues between day 6 and the time of sponge removal. The size of the DF on day 12 was also smaller in ewes that have the largest follicle removed at the time of sponge removal reflecting that these follicles had a shorter period of growth; however, the rate of growth was greater for these follicles than for follicles arising after cauterization on day 3 or 6 after sponge insertion. There were no differences among treatments, in the number of ewes that formed a corpus luteum (CL) in response to hCG. Life span of the corpora lutea did not differ among ewes having their DF removed on day 6 or 9 or those that served as controls, however, ewes that had their DF removed on day 3 developed longer lived CL in a larger proportion of animals. Average progesterone concentration during the life span of the induced corpora lutea was greater in control ewes than in any other experimental group. These observations allow us to conclude that, (a) the follicular dynamics observed in anestrous ewes treated with a progestin intravaginal sponge resembles that observed during the normal estrous cycle in the ewe; (b) the effects of progesterone on life span of the corpus luteum could not be only related to direct effects at the follicle but also involve changes in other components of the uterine-ovarian-hypothalamic axis; (c) the mechanisms controlling luteal life span seem to be different to those mechanisms controlling the function of the induced corpus luteum.

Frequency of luteinizing hormone pulses in cattle influences duration of persistence of dominant ovarian follicles, follicular fluid concentrations of steroids, and activity of insulin-like growth factor binding proteins.

The objectives of the present study were to determine how varying frequency of LH pulses as controlled by varying treatments with progesterone (P4) in cattle would affect: (1) concentration of steroid hormones and activity of insulin-like growth factor binding proteins (IGFBPs) in the ovarian follicular fluid and blood plasma, and (2) duration of persistence of largest ovarian follicles. There were four treatment groups (n=7 per group) and a control group (n=5) of mature, non-lactating beef cows. Treatments were: (1) two progesterone releasing intravaginal devices (PRIDs) for 16 days (2PRID); (2) a half PRID for 16 days (0.5PRID); (3) two PRIDs for 8 days, then a half PRID for 8 days (2-0.5PRID); or (4) a half PRID for 8 days, then two PRIDs for 8 days (0.5-2PRID). Treatment was initiated on the fifth day of the estrous cycle, which was designated as Day 0, and continued for 16 days. All P4-treated females were administered prostaglandin F2alpha on Day 0 and 1 to regress their corpora lutea. Frequency of LH pulses was greater during treatment with the smaller dose of P4 compared with treatment with the larger dose of P4 and the control group. Ovarian follicles were classified into five categories based on ultrasonographic observations: growing (G); atretic (A); growing dominant (GD); growing persistent (GP); or atretic persistent (AP). At ovariectomy on Day 16, the largest and second largest follicles collected were re-classified into five categories based on follicular concentration of steroids. Classification of the largest follicle collected on Day 16 was influenced by treatment (P<0.005), with the 2PRID group having A follicles, the 2-0.5PRID group GP follicles, the 0.5-2PRID group AP follicles, and the 0.5PRID group GD and GP follicles. Concentrations of 17beta-estradiol (E2) were greatest in GD and GP follicles (P<0.05). There was less (P<0.05) activity of IGFBP-2 in GD follicles and less (P<0.05) activity of IGFBP-3 in GD and GP follicles than other follicles. Activity of IGFBP-4 and -5 was greater (P<0.05) in A and AP follicles than G, GD, and GP follicles. Maintenance of a frequent release of LH pulses over a 16-day period did not result in maintenance of persistent follicles throughout this period indicating that duration of dominance of these follicles is finite even when there is frequent release of LH pulses. Follicular atresia is associated with greater activity of IGFBP-2, -4, -5, and greater concentrations of P4 in follicles, whereas growing dominant and persistent follicles contained greater concentrations of E2, androstenedione (A4), and less IGFBP-2 activity than follicles of other classes. Follicle classifications based on ultrasonography or follicular concentration of steroids did differ (P<0.05) for the largest follicles from the 2PRID group. Two follicles in this group appeared as GD follicles by ultrasonography, but these were atretic based on follicular steroid contents. Objective 1 of the present study yielded the conclusion that concentrations of steroid hormones in follicular fluid and blood plasma could be predictably controlled by regulating the frequency of LH pulses with varying doses of P4. Objective 2 yielded the conclusion that maintain frequent release of LH pulses over a 16-day period could not maintain persistent follicles throughout this period, indicating that duration of dominance of these follicles is finite even when there is frequent release of LH pulses. Follicular atresia in the present study was associated with increased follicular fluid activity of IGFBP-2, -4, -5, and P4, whereas growing dominant and persistent follicles contained greater concentrations of E2, A4, and less IGFBP-2 activity than follicles of other classes.

Bull exposure and an increased within-day milking to suckling interval reduced postpartum anoestrus in dual purpose cows.

It is hypothesized that the combined effects of suckling and milking in the dual purpose cows is one of the main suppressors of reproductive efficiency in this production system. The experiment described here examined whether managing the interval between milking and suckling could reduce the postpartum anoestrous period and whether the presence of a teaser bull could enhance the effects of these managements. The experiment involved 39 Bos taurus x Bos indicus cows which had an average weight of 523.0 +/- 12.8 kg (mean +/- S.E.M.) and body condition score of 5-7 (scale 1-9) at calving. The cows and calves grazed separate pastures and the cows were supplemented with 2 kg 17% CP concentrates and 1 kg molasses per cow per day. The experiment was conducted over the first 100 days postpartum. Cows were hand-milked once per day in the presence of the calf to stimulate milk release. The factors in the 2 x 2 design were the milking to suckling interval (0 h, control suckling; CS versus 8 h prolonged-delay suckling; PDS) and no exposure versus exposure to a teaser bull (B). Cows were assigned at random within calving date to the four treatments: CS (n = 10), PDS (n = 10), CS-B (n = 9) and PDS-B (n = 10). Cows on treatments CS and CS-B had three-quarters of the udder milked and one-quarter was not milked. The entire udder was milked on those treatments where there was an interval between milking and suckling. The bull was introduced 7 days after calving in treatments where the cows were exposed to a teaser bull. Body weights of cows and calves and cow milk yield were recorded. Weekly blood samples were collected for plasma progesterone assay. Data were analyzed by ANOVA in a 2 x 2 factorial design and by chi(2)-test. There were no statistically significant differences between treatments in cow body weight at calving and at 100 days postpartum, nor in milk yield (overall mean 6.0 +/- 1.1 kg per day). Calf daily gain was 598 +/- 25 g for treatments CS and CS-B in which suckling immediately followed milking and 833 +/- 24 g for treatments PDS and PDS-B (P < 0.001). The proportion of cows ovulating was CS 80.0%, PDS 100.0%, CS-B 88.8% and PDS-B 100.0%. The difference between CS and PDS or PDS-B was significant (P < 0.05). CS-B did not differ significantly from the other three treatments. The calving to first ovulation interval was not improved when the interval between milking and suckling was increased from 0 h (56.5 +/- 5.0 days) to 8 h (64.8 +/- 4.5 days). Exposure to a teaser bull, however, significantly (P < 0.001) reduced this interval from 77.0 +/- 2.7 days (no bull exposure) to 44.4 +/- 2.7 days (exposure to teaser bull). Exposure to a teaser bull significantly reduced the calving to first anoestrus interval. Delaying the start of suckling after milking did not improve the reproductive performance of the cows or alter the effect of bull exposure, however, delaying suckling after milking improved the performance of the calves without affecting milk yield.

Postpartum anoestrus is reduced by increasing the within-day milking to suckling interval in dual purpose cows.

In the dual purpose milk/beef production system practised in Mexico, the cows are milked once a day in the presence of the calf and then the calf suckles for the next 1-8 h. It was hypothesised that the imposition of milking and suckling in close succession contributes to the long postpartum anoestrous periods experienced by cows in this system. Therefore, separating these two inhibiting factors, by delaying the start of suckling after milking would lower the impact on the hypothalamus-hypophysial axis and allow it to recover more readily. This hypothesis was tested in two experiments using Bostaurus x Bosindicus cows which weighed 541.3 +/- 12.7 kg (mean +/- S.E.M.; experiment 1) and 537.8 +/- 10.6 kg (experiment 2) and had a body condition score of 5-6 (scale 1-9) at calving. The cows and calves were maintained on separate pastures and the cows were offered concentrate supplements. Experiment 1 was conducted in the dry season and cows were offered a daily supplement of 3 kg of 17% crude protein (CP) concentrates plus 1 kg molasses per cow. Experiment 2 was conducted during the wet season and the nutritional supplement consisted of only 1 kg of 17% CP plus 1 kg molasses per cow per day. Each experiment lasted for the first 100 days postpartum and the cows were not mated during this time. Cows were hand-milked once a day in the presence of the calf to stimulate milk let-down. In experiment 1, 30 multiparous cows were assigned at random by date of calving, to one of three treatments: controlled suckling (CS; n = 10), delayed suckling (DS; n = 10) and prolonged delayed suckling (PDS; n = 10). The suckling period on all treatments lasted for 2 h and started at 0 h (CS), 4 h (DS) or 8 h (PDS) after milking. In experiment, 34 multiparous cows were assigned at random to three treatments: CS (n = 11), PDS (n = 11) or prolonged delayed short suckling (PDSS; n = 12), in this last treatment the suckling period was reduced to only 30 min. In both experiments, one quarter of the udder of cows on treatment CS was not milked but all the udder was milked on the other treatments. Body weights of cows and calves and cow milk yields were recorded. Weekly blood samples were collected for plasma progesterone assay to detect the first postpartum corpus luteum. Data were analysed by ANOVA and chi-square test. Cows in experiment 1 had similar weight changes during the first 100 days postpartum. Milk production was higher for DS (8.0 +/- 0.7 kg per day) and PDS (7.0 +/- 0.5 kg per day) cows than for CS (5.2 +/- 0.7 kg per day) cows (P < 0.01). Calf daily gain was greater (P < 0.05) for PDS (827 +/- 35 g per day), than CS (702 +/- 26 g per day) or DS (715 +/- 29 g per day). The proportion of cows ovulating during the first 100 days postpartum were 50.0, 70.0 and 100.0%, for CS, DS and PDS, respectively (P < 0.05). The intervals from calving to first significant rise in progesterone were 70.4 +/- 1.6, 72.1 +/- 1.3 and 64.6 +/- 1.5 days for CS, DS and PDS (P > 0.05), respectively. In experiment 2, cow body weight during the first 100 days postpartum did not differ between treatments. Milk production was not significantly different between CS (7.3 +/- 1.0 kg per day) and PDSS (6.8 +/- 1.0 kg per day), but was higher (P < 0.05) for CS than PDS (5.2 +/- 1.0 kg per day). Calf daily gain was lower for CS (576 +/- 31 g per day; P < 0.05) than PDS (779 +/- 38 g per day) and PDSS (780 +/- 20 g per day). The proportion of cows ovulating was higher (P < 0.05) for treatments PDS (100%) and CS (81.8%) than PDSS (50%). Calving to first ovulation interval was shorter (P < 0.05) for PDS (57.3 +/- 4.5 days) and PDSS (49.7 +/- 3.0 days) cows than CS (72.1 +/- 3.5 days) cows. It is concluded that delaying suckling for 8 h after milking, increases the proportion of cows ovulating within 100 days of calving, shortened the calving to first ovulation interval and improved calf performance without adversely affecting cow milk yield or body weight change.

Haemodynamics of arteriovenous malformations of the brain and consequences of resection: a review.

The physiological manifestations of arteriovenous fistulae in humans have been studied since the 18th century. However, confusion regarding concepts of cerebral 'steal', 'normal perfusion breakthrough', and 'congestive hyperaemia' continue. Although the advent of more accurate monitoring of pressures and flows within the brain has provided useful information to help understand some of these proposed pathological hypotheses, disagreement still exists. The purpose of this review is to examine the current physiological data in attempt to explain the clinicopathological manifestations of arteriovenous malformations of the brain and the consequences of their removal.

Ovulation and luteal characteristics following removal of the ovine corpus luteum (lutectomy) at four times during the oestrous cycle.

The life span of the corpus luteum (CL) may depend on follicular development. To provide evidence relating to this hypothesis, each of 32 ewes was randomly assigned to have its CL removed on day 2, 3, 4 or 10 after oestrus. Twenty ewes were treated with 1000 IU of human chorionic gonadotrophin (hCG) 36 h after CL removal to induce ovulation; the other 12 ewes were not treated with hCG. Blood samples were collected daily to monitor the ovulatory response and the characteristics of the next cycle at the first sign of oestrus and up to day 21 after surgery or hCG administration. Every animal ovulated within 7 days of hCG administration, regardless of when its CL had been removed. It was concluded that the follicles found in the ovary as early as the second day after oestrus respond to endogenous or exogenous ovulatory stimuli affecting the life span of resulting CL.

Ovarian follicular development in prepubertal heifers is influenced by level of dietary energy intake.

Objectives were twofold: 1) to determine the chronology of development of dominant ovarian follicles during the peripubertal period in heifers and 2) to determine whether feeding a diet with low energy content that delays onset of puberty alters chronology of dominant ovarian follicular development in peripubertal heifers. Ten heifers of composite breeding (1/4 Angus, 1/4 Hereford, 1/4 Red Poll, 1/4 Pinzgauer) were randomly assigned, at 8 mo of age, to receive a diet designed to produce 0.9 (n = 5) or 0.3 (n = 5) kg body weight gain per day for the duration of the experiment. To characterize changes in size of ovarian follicles, real-time linear ultrasonography of ovaries was conducted in all heifers every other day until puberty occurred. Blood samples were collected weekly to determine concentrations of progesterone and 17 beta-estradiol. Determination of time of puberty was based on increased concentrations of progesterone, ultrasound depiction of ovulation, and subsequent presence of a corpus luteum. Size of the dominant ovarian follicles differed prior to puberty (p < 0.03); diameter of the dominant ovarian follicle was greater in all heifers as the first ovulation approached as compared to earlier in prepuberty. Heifers fed the greater amount of energy exhibited larger dominant ovarian follicles at a younger age in comparison to heifers fed the lower amount of energy.(ABSTRACT TRUNCATED AT 250 WORDS)

Circulating concentrations of 17-estradiol influence pattern of LH in circulation of cows.

The objective of the research was to determine the relationship between circulating 17 beta-estradiol (E2) and secretion of luteinizing hormone (LH) in cows. A second objective was to determine if response to E2 was influenced by interval between ovariectomy and the start of E2 treatment. Thirty-one nulliparous cows 3 yr of age were randomly assigned to a 2 x 4 factorial arrangement of treatments. Sixteen cows were ovariectomized at 18 mo of age (long term), and the other 15 cows were ovariectomized at 36 mo of age (short term). At the time of ovariectomy of cows in the short term group, 11 cows in the short term group and 12 cows in the long term group were implanted subcutaneously with 1, 2 or 4 polydimethylsiloxane capsules containing E2. The other eight cows served as non-implanted controls (n = 4-short term, n = 4-long term). All cows were fitted with jugular vein catheters on day 29 of treatment, and on day 30 blood samples were collected at 12-min intervals for 6 hr. At the end of 6 hr, luteinizing hormone-releasing hormone (LHRH) was administered and blood sampling continued at 12-min intervals for an additional hour. Serum was analyzed for LH and E2. Variables of LH secretion analyzed were mean concentration, frequency of pulses, amplitude of pulses and maximum concentration after LHRH. There were no significant interactions for any of the variables of LH among cows ovariectomized for the long and short term. There was a significant linear increase in mean concentration of LH with increased circulating concentration of E2.(ABSTRACT TRUNCATED AT 250 WORDS)

Estrus synchronization in Holstein cows using reduced doses of prostaglandin F(2)alpha.

There is evidence that the dose of PGF(2)alpha generally used to synchronize estrus (25 mg) is higher than required to induce luteolysis in cattle. To investigate this, 98 Holstein cows from three farms were assigned at random within farm to be treated with a single dose of 25 mg (n=33), 17.5 mg (n=33) or 10 mg (n=32) of PGF(2)alpha on Day 10+/-0.5 (mean +/- SEM) of the estrous cycle. Statistical analyses were conducted using analyses of variance and Chisquare test. Only 59.3% of the cows treated with 10 mg of PGF(2)alpha were detected in estrus compared with 72.7 and 78.7% of the cows treated with 17.5 and 25.0 mg doses, respectively (P>0.05). There were no differences (P>0.05) in pregnancy rates at the first service (40.0, 66.6 and 50.0% for 25, 17.5 and 10 mg, respectively). Concentrations of progesterone in blood were different (P<0.05) for cows treated with 10 mg compared with those of cows treated with 17.5 or 25 mg of PGF(2)alpha. The pattern of changes in progesterone concentrations between the last two groups was not different, and progesterone concentrations of less than 1 ng/ml of serum were observed within the first 36 h post PGF(2)alpha administration. In cows treated with 10-mg dose of PGF(2)alpha, concentrations of progesterone declined during the first 24 h, however, by the end of the experimental period, they were not different to pretreatment concentrations (treatment x time; P<0.05). It is suggested that reducing the dose of PGF(2)alpha from 25 to 17.5 mg do not affect estrus response or pregnancy rate in Holstein cows.

Caries and the preschool child: implications within the community dental service.

The financial and organizational implications for the treatment of preschool children within the community dental service require careful planning and consideration. Kent Community Dental Service provides regular general anaesthetic sessions for the treatment of caries in preschool children and an assessment of the costs is provided and discussed.

Changes in hormonal profiles during the estrous cycle in old lactating beef cows.

Patterns of concentrations of luteinizing hormone (LH), follicle stimulating hormone (FSH), progesterone (P4) and estradiol-17 beta (E2) during an estrous cycle were compared between 15 lactating beef cows 5 to 7 years of age (young) and 15 cows greater than or equal to 12 years of age (old). Length of estrous cycle did not differ between young and old cows (P = .06). No differences due to age were found for LH. Patterns of concentrations of P4 during the first 15 days of the cycle, of FSH during days 6 through 12 and of E2 during the follicular phase differed with age (P less than .05). An earlier (P less than .025) midcycle elevation of FSH was associated with an earlier rise and greater concentration of E2 (P less than .05) during the follicular phase in old than in young cows. Differences in FSH and P4, although subtle, were consistent with an earlier or more advanced follicular development in old cows, leading to greater secretion of E2 from the preovulatory follicle.

Effect of age and norgestomet on endocrine parameters and production of embryos in superovulated beef cows.

Effects of age of cow and a norgestomet (N) implant on number of embryos and endocrine responses to induction of superovulation were studied in old (greater than 12 yr) and young (5 to 7 yr) lactating beef cows. Seventeen cows (8 old and 9 young) received a 6-mg N ear implant on d 4 or 5 of the cycle (d 0 = estrus); the remaining 17 cows (9 old and 8 young) served as untreated controls (C). All animals were treated with 38 mg of porcine follicle-stimulating hormone (FSH-P) in decreasing dosages over a 4.5-d period beginning on d 10 or 11. Regression of the corpus luteum was induced with injections of PGF2 alpha at 0800 and 2000 on d 4 of FSH-P treatment; implants were removed at the second injection of PGF2 alpha. Cows were inseminated artificially 12 and 24 h after onset of estrus. Embryos were collected on d 7 or 8 postinsemination. Blood samples were obtained daily at 0800 from 2 d prior to initiation of treatment with FSH-P until collection of embryos. An additional sample was collected each day at 2000, from the first injection of PGF2 alpha to 1 d after onset of estrus. Samples were assayed for luteinizing hormone (LH), progesterone (P4), follicle stimulating hormone (FSH) and estradiol-17 beta (E2). Total number of embryos plus ova recovered was lower (P less than .01) in N-treated (5.2 +/- 1.1) than in C-treated (10.6 +/- 1.6) cows.(ABSTRACT TRUNCATED AT 250 WORDS)

Receptors for luteinizing hormone and follicle-stimulating hormone in largest follicles of postpartum beef cows.

Follicles collected from cows destined to enter relatively normal or short luteal phases if induced to ovulate were compared for numbers of receptors for luteinizing hormone (LH) in granulosal and thecal cells and for follicle-stimulating hormone (FSH) in granulosal cells. Eleven suckled beef cows received ear implants of 6 mg norgestomet for 9 days (expected normal luteal phase) and 11 served as controls (expected short luteal phase). At 48 h after implants were removed (average 34 days postpartum), the ovary containing the largest follicle was identified by transrectal ultrasound and removed. The largest follicle was dissected free of surrounding ovarian stroma and frozen in liquid nitrogen. Thecal and granulosal cells were isolated, and numbers of receptors for LH and FSH in granulosal cells and for LH in thecal cells were quantified. Concentrations of estradiol were measured in follicular fluid. Both granulosal and thecal cells from norgestomet-treated cows had greater numbers of receptors for LH than did those from control cows (p less than 0.01). Numbers of receptors for FSH in granulosal cells did not differ between treated and control cows. Follicles from norgestomet-treated cows were heavier (p less than 0.01) than follicles from control cows, mostly due to greater amounts of follicular fluid (p less than 0.01). Concentrations of estradiol were higher in follicular fluid from the treated cows (p less than 0.05). It is suggested that increases in numbers of follicular receptors for LH and secretion of estradiol are integral components of a sequence of events by which norgestomet prepares follicles to become fully functional corpora lutea.

Ovulation in postpartum beef cows treated with estradiol.

The effect of implants of estradiol on initiation of ovarian cycles postpartum was studied in 201 anestrous beef cows. Cows from four farms were used over a 2-yr period in a 2 x 3 factorial arrangement of treatments with estradiol implants and stage postpartum as main effects. Cows were assigned at random within date of calving within farm to receive an ear implant containing estradiol-17 beta (24 mg) for 21 d or to serve as controls. Stages postpartum at implantation were divided into less than or equal to 25, 26 to 39, and greater than or equal to 40 d, three stages that should reflect potential changes in hypothalmic-hypophysial sensitivity to estradiol. Blood samples for determination of progesterone were obtained and rectal examinations of the ovaries performed at implant insertion, 14 d after insertion, at implant removal (d 21), and 14 d after removal (d 35) to assess ovulatory response to treatment. Circulating concentrations of estradiol on d 14 of treatment averaged 3.2 +/- 1.0 and 23.1 +/- 4.7 pg/ml for control and estradiol-treated cows, respectively. Compared with control cows, treatment with estradiol initiated after d 26 postpartum increased the proportion of cows that ovulated during the experimental period. No differences were seen in the average days postpartum when cows were first determined to have ovulated.

Effects of norgestomet on follicular development in postpartum beef cows.

To examine effects of norgestomet pretreatment on development of follicles and their response to administration of gonadotropin releasing hormone (GnRH), 45 pluriparous suckled beef cows were assigned at random to receive a 6-mg implant of norgestomet for 9 d (inserted 24 d postpartum) or serve as untreated controls. Ovaries were obtained 48 h after removal of implants or 10 to 11 or 20 to 22 h after im administration of 150 micrograms GnRH at 48 h after removal of the implant. The largest follicle (F1) and all follicles within 3 mm in diameter of the F1 were dissected from the ovaries. Theca, granulosa and follicular fluid were separated and assayed for steroids and prostaglandins. Diameters and weights of F1 and weights of follicular components remained unchanged in control cows, but increased by 10 h and declined by 20 h in norgestomet-pretreated cows (treatment X time, quadratic, P less than .05). Ovarian volume and numbers of follicles at the surface of the ovary did not differ with treatment, but the diameter of the second-largest follicle (F2) was smaller (P less than .05) in norgestomet-pretreated cows than in controls (6.0 +/- .9 vs 8.2 +/- .7 mm). The F1 were embedded in the ovary in fewer norgestomet-pretreated than control cows (2/22 vs 8/23; P less than .05). Changes in steroids in F1 paralleled those in size (treatment X time, quadratic, P less than .05). Overall, F1 from norgestomet-pretreated cows had higher (P less than .05) contents of estradiol. Contents of prostaglandins in F1 follicles did not differ with treatment, but increased (P less than .05) following treatment with GnRH. The F2 had lower contents of estradiol than F1. It is suggested that norgestomet effected the maturation of a single follicle which produced more estradiol.